Valproate Products: Drug Safety Communication – Risk of Impaired Cognitive Development in Children Exposed In Utero (During Pregnancy)

Audience: OBGYN, Neurology, Psychiatry Including valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER), valproic acid (Depakene and Stavzor), and their generics
ISSUE: FDA notified healthcare professionals that…

Angiotensin Receptor Blockers (ARBs): Drug Safety Communication – Drug Safety Review Completed Audience: Cardiology, Oncology, Family Practice [UPDATED 06/02/2011] FDA’s meta-analysis of...

FREE Case Review

Defective DrugsAdverse reactions to medications on the market.

Personal InjuryPersonal injuries resulting from negligence may lead to significant medical expenses.

Toxic ExposureDangerous toxins linked to cancers, birth defects, and chronic respiratory problems.

DiseasesDangerous toxins linked to cancers, birth defects, and chronic respiratory problems.

Financial FraudsUnethical actions by large corporations may cause financial hardship.

Medical MalpracticeMedical errors or negligent health care resulting in injury or death.

Valproate Products: Drug Safety Communication – Risk of Impaired Cognitive Development in Children Exposed In Utero (During Pregnancy)

FREE Case Review

Trending Topics